Recent Posts
News•Mar 1, 2026
GoodRx Launches Employer Program to Help Subsidize High-Cost Brand Drugs
GoodRx introduced GoodRx Employer Direct, a new service allowing employers to directly subsidize the manufacturer‑sponsored price of high‑cost brand medications such as GLP‑1 drugs without adding them to health‑plan formularies. The model, first piloted with retailer Hy‑Vee, lets employers contribute funds that are applied automatically at the pharmacy counter, complementing existing prescription‑savings coupons. GoodRx also offers tailored telemedicine programs, like GoodRx for Weight Loss, to pair clinical care with drug access. The company will monitor employer and patient uptake to assess the program’s impact.
By MedCity News
News•Feb 27, 2026
Where the Patient Experience Is Heading – And 3 Ways Healthcare Providers Can Meet That Moment
Telehealth surged from 15% to 86% of physicians between 2019 and 2021, and a 2024 survey shows 94% of patients would repeat virtual visits. This shift has turned remote care into a baseline expectation. AI is now poised to deepen...
By MedCity News
News•Feb 27, 2026
How Elevance Health Is — and Isn’t — Using AI
Elevance Health, formerly Anthem, is deploying artificial intelligence across its operations while drawing a firm line against using AI for claim denials. The insurer leverages AI to flag incomplete claims, accelerate prior‑authorization approvals, and power virtual assistants that guide members...
By MedCity News
News•Feb 26, 2026
Collective Health Collaborates with Google Cloud to Launch New AI-Powered System
Collective Health has unveiled Collective AI, an AI‑powered benefits assistant built with Google Cloud. The system answers member queries, supplies real‑time data to customer‑service reps, and offers employers plan‑design insights to streamline enrollment. Leveraging Google Cloud’s privacy‑by‑design infrastructure, the tool...
By MedCity News
News•Feb 26, 2026
Compliance: Why Your Vendor’s Vendor Is a Growth Risk
Healthcare providers are increasingly dependent on multi‑layered vendor ecosystems to deliver AI, blockchain and IoT solutions, extending HIPAA liability to every downstream partner. The rise of “nth‑party” suppliers creates a hidden growth tax, delaying projects, inflating M&A costs, and exposing...
By MedCity News
News•Feb 25, 2026
Valo Health CEO: We Don’t Want Investors To Drive the Science
Valo Health is reshaping drug development by applying AI to human causal biology, aiming to raise clinical success rates from roughly 10% to 20%. The company leverages over 17 million de‑identified patient records and Mendelian randomization to pinpoint genetically validated targets....
By MedCity News
News•Feb 25, 2026
4 Health Tech Trends Startups Can’t Ignore, Per an Oak HC/FT Partner
Oak HC/FT partner Vig Chandramouli highlighted four health‑tech trends that startups must address to win investor confidence. First, labor management for nurses and allied professionals—who comprise 70% of the workforce—is a largely untapped market. Second, investors are scrutinizing margins, finding...
By MedCity News
News•Feb 24, 2026
Headache Startup Slate Medicines Lands $130M to Bring Novel Migraine Drug Into the Clinic
Slate Medicines, a Raleigh‑based biotech, secured $130 million in Series A funding to advance its anti‑PACAP monoclonal antibody, SLTE‑1009, into Phase 1 trials slated for mid‑2026. The drug targets pituitary adenylate cyclase‑activating polypeptide (PACAP), an alternative migraine pathway distinct from the widely used...
By MedCity News
News•Feb 24, 2026
Top-Rated Gel Packs for Physical Therapy: Best Brands and Where to Buy
Healthcare leaders and clinicians are evaluating top‑rated gel packs for physical therapy, focusing on durability, temperature retention, and supply‑chain reliability. Leading providers include Pelton Shepherd, Chattanooga ColPac, Elasto‑Gel, Core Products, and Cardinal Health, each offering reusable hot and cold packs...
By MedCity News
News•Feb 24, 2026
2026 Star Ratings Shift: 4 Strategies for MA Plans
CMS has unveiled a sweeping overhaul of the Medicare Advantage Star Ratings, targeting the 2028 and 2029 rating cycles. The agency will drop 12 administrative and two clinical measures, eliminate the Health Equity Index incentive, and introduce a depression‑screening metric....
By MedCity News
News•Feb 24, 2026
How AI Is Transforming Detection of Congenital Heart Defects
AI‑enabled ultrasound is emerging as a tool to improve prenatal detection of congenital heart defects (CHDs), which affect about 1 % of U.S. births and are frequently missed. FDA‑cleared AI platforms can analyze cardiac images in real time, flagging abnormal views...
By MedCity News
Deals•Feb 24, 2026
Slate Medicines Secures $130M Series A Funding Led by RA Capital, Forbion and Foresite Capital
Slate Medicines, a North Carolina‑based biotech startup, announced a $130 million Series A round to fund development of its PACAP‑blocking migraine antibody SLTE‑1009. The round was led by RA Capital, Forbion and Foresite Capital, with participation from an undisclosed biotech investor. The...
MedCity News
News•Feb 23, 2026
Care.com and Headspace Launch Mental Health Partnership for Caregivers
Care.com and Headspace announced a partnership to bolster mental‑health support for family caregivers. The collaboration introduces ten exclusive micro‑mindfulness videos, each under three minutes, and provides free Headspace subscriptions to Care.com members. The initiative responds to data showing roughly one‑third...
By MedCity News
News•Feb 23, 2026
Designing Scalable Measurement-Based Care Systems for Expanding Health Care Organizations
Measurement‑Based Care (MBC) uses patient‑reported outcome measures like PHQ‑9 and GAD‑7 to turn subjective symptoms into quantitative data, driving up to 95 % improvement in outcomes. As patient volumes grow, manual MBC processes become inefficient, leading to incomplete assessments, clinician burnout,...
By MedCity News
News•Feb 23, 2026
Why HealthTech Products Fail Clinical Deployment & How To Prevent It
Health‑tech AI pilots are booming, yet MIT’s 2025 State of AI report finds 95% fail to generate value. High‑profile failures like Forward Health’s CarePods and Olive AI illustrate how operational complexity and unfocused expansion derail scaling. The article argues that...
By MedCity News
Deals•Feb 18, 2026
Eli Lilly Pays $100M for Rights to CSL’s Clazakizumab
Eli Lilly announced it will pay $100 million to CSL Limited for the rights to the IL‑6‑blocking antibody clazakizumab, with CSL retaining rights for cardiovascular prevention in end‑stage kidney disease patients. The deal includes an upfront payment and potential milestone and...
MedCity News